Skip to content
CompanySight
Company No. 03929804 · Incorporated 21 Feb 2000

Ibsa Pharma Limited

Registered name: IBSA PHARMA LIMITED

Ibsa Pharma Limited made £22.5m revenue and £412k profit in the year to 31 Dec 2025.

Ibsa Pharma Limited’s revenue grew 10% to £22.5m in the year to 31 Dec 2025, with £412k profit and 49 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Watford; we hold 4 years of its filed accounts.

Status
Active
Location
Watford, East of England
Age
26 yrs · since 2000
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “IBSA Institut Biochimique SA”

Latest accounts · year to 31 Dec 2025

Key figures

Capital-lightCash flow filed
Revenue
£22.5m
Growth ▲10.1%
Profit
£412k
Growth ▼38.8%
Profit margin
1.8%
Gross 37.2%
Employees
49
Change ▲22.5%
Profit / employee
£8.4k
Revenue/employee £460k
Profitable streak
4yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 202331 Dec 202431 Dec 2025
DisclosureFull P&Lread from filing textFull P&Lread from filing textFull P&LFull P&L
Profit & loss
Revenue (turnover)£11.5m£17.7m£20.5m£22.5m
Cost of sales£5.5m£12.4m£13.8m£14.1m
Gross profit£6m£5.3m£6.6m£8.4m
Operating profit£4m£633k£785k£467k
Profit before tax£4m£742k£908k£555k
Profit after tax£3.3m£568k£673k£412k
Profit (best available)£3.3m£568k£673k£412k
Staff costs£1.6m£2.4m£2.8m£3.8m
Employees (average)29404049
Ratios
Profit margin28.7%3.2%3.3%1.8%
Gross margin52%29.9%32.4%37.2%
Revenue per employee£398k£441k£511k£460k
Profit per employee£114k£14.2k£16.8k£8.4k
Cash conversion−20.3%−348.4%326.8%−176.1%
Growth (year on year)
Revenue growth——▲15.8%▲10.1%
Profit growth——▲18.6%▼38.8%
Headcount growth——0%▲22.5%
Balance sheet — indirect signals, not revenue
Cash at bank£10.7m£6.9m£4.3m£3.4m
Net assets£12.7m£7.2m£7.9m£8.3m
Fixed assets£136k£124k£586k£642k
Current assets£15.8m£11.8m£12.4m£11.5m
Debtors£1.4m£1.4m£1.5m£1.5m
Deferred income£461k£562k£636k—
Cash from operations−£818k−£2.2m£2.6m−£823k
SourceFullAccounts · bulk data Apr 2024FullAccounts · bulk data Apr 2024FullAccounts · bulk data Feb 2025FullAccounts · bulk data Feb 2026
Derived from the latest filing

How the business works

Profit margin
1.8%
Profit ÷ revenue.
Gross margin
37.2%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£460k
Revenue ÷ average employees.
Profit per employee
£8.4k
Profit ÷ average employees.
Cash conversion
−176.1%
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
2.9%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
6.8%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲5%
Now £8.3m
Cash at bank
▼20%
Now £3.4m
Headcount
▲23%
Now 49
Deferred income
—
Now —
Fixed assets
▲10%
Now £642k
Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £412k), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.